RELVAR ELLIPTA 184 micrograms/22 micrograms, powder for inhalation, in a single-dose container 30 doses
Active ingredients: Fluticasone furoate, Vilanterol trifenatate, Vilanterol
Commercialized according to BDPMDispensing in France: Prescription only
Powder and powder for inhalation30 dosesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RELVAR ELLIPTA 184 microgrammes/22 microgrammes, poudre pour inhalation, en récipient unidose
- Pharmaceutical form
- poudre et poudre pour inhalation
- Route of administration
- inhalée
- Presentation description
- 1 plaquette(s) aluminium de 30 dose(s) - 1 plaquette(s) de 30 dose(s) avec inhalateur(s)
- Marketing authorisation holder
- GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Nov 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61740809CIP72762010CIP133400927620102Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUROATE DE FLUTICASONEpoudre de furoate de fluticasone | 184 microgrammes · une dose délivrée | SA |
| VILANTÉROLpoudre de vilantérol de trifénatate | 22 microgrammes · une dose délivrée | FT |
| TRIFÉNATATE DE VILANTÉROLpoudre de vilantérol de trifénatate | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.